Close
Back to CODX Stock Lookup

(CODX) – Company Press Releases

Aug 11, 2022 04:01 PM Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Aug 2, 2022 09:30 AM /C O R R E C T I O N -- Co-Diagnostics/
Jul 27, 2022 09:30 AM Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in Chicago
Jul 26, 2022 09:30 AM Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC
Jul 20, 2022 09:30 AM Co-Diagnostics, Inc. to Host Booth at AACC Held July 24-28 in Chicago
Jul 11, 2022 09:30 AM Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test
Jun 28, 2022 09:30 AM Co-Diagnostics, Inc. to Present at 29th International Biodetection Technologies Virtual Conference
Jun 15, 2022 09:30 AM Co-Diagnostics, Inc. to Present at Sidoti Summer Small Cap Virtual Conference
Jun 9, 2022 09:30 AM Co-Diagnostics, Inc. to Host Booth at MEDEXPO Africa 2022 in Nairobi, Kenya on June 9-11
May 26, 2022 09:30 AM Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus
May 19, 2022 09:30 AM Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26
May 12, 2022 04:01 PM Co-Diagnostics Reports Solid First Quarter 2022 Financial Results
May 3, 2022 09:30 AM Co-Diagnostics, Inc. to Host Booth at Medical Fair Brasil 2022 in São Paulo on May 3-6
Apr 28, 2022 09:30 AM CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST
Apr 22, 2022 09:30 AM Co-Diagnostics, Inc. to Host Booth at ECCMID 2022 in Lisbon, Portugal on April 23-26
Apr 19, 2022 09:30 AM Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test
Mar 24, 2022 04:01 PM Co-Diagnostics Reports Full Year 2021 Financial Results
Mar 17, 2022 09:30 AM Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board
Mar 15, 2022 09:30 AM Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program
Mar 14, 2022 09:30 AM CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCAST
Feb 17, 2022 09:30 AM Co-Diagnostics, Inc. to Sponsor and Present at Molecular Med Tri-Con 2022
Feb 10, 2022 09:30 AM Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital
Feb 3, 2022 09:30 AM Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test
Jan 21, 2022 09:30 AM Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2022 in Dubai on January 24-27
Jan 13, 2022 09:30 AM Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test
Jan 10, 2022 06:30 AM Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13
Dec 31, 2021 09:30 AM Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform
Dec 22, 2021 09:25 AM Co-Diagnostics, Inc. Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform
Dec 7, 2021 04:00 PM Creator of COVID-19 and Global Molecular Testing Products Co-Diagnostics, Inc. Launches Retail Investor and Perks Program with TiiCKER
Dec 7, 2021 09:25 AM Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test
Nov 29, 2021 08:00 AM Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant
Nov 15, 2021 11:30 AM Co-Diagnostics, Inc. to Host Booth at MEDICA 2021 Trade Fair in Düsseldorf, Germany
Nov 11, 2021 04:01 PM Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results
Nov 4, 2021 09:38 AM Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom
Oct 28, 2021 12:00 PM Co-Diagnostics, Inc. Announces Third Quarter 2021 Earnings Release Date And Webcast
Oct 6, 2021 10:54 AM Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test
Sep 27, 2021 09:30 AM Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28
Sep 23, 2021 09:30 AM Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion
Sep 21, 2021 04:15 PM Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece
Sep 21, 2021 09:30 AM Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico
Sep 20, 2021 05:03 PM Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference
Sep 16, 2021 09:30 AM Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests
Sep 13, 2021 06:30 AM Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor Conference
Sep 8, 2021 09:30 AM Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy
Aug 23, 2021 09:30 AM Co-Diagnostics, Inc. To Present At 13th Next Generation Dx Summit In Washington, D.C.
Aug 12, 2021 04:01 PM Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results
Aug 4, 2021 11:30 AM Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast
Jul 22, 2021 09:30 AM Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent
Jun 18, 2021 01:36 PM Proactive news headlines including Co-Diagnostics, Esports Entertainment, Versus Systems and Plurilock Security
Jun 18, 2021 01:36 PM Proactive news headlines including Co-Diagnostics, Esports Entertainment, Versus Systems and Plurilock Security

Back to CODX Stock Lookup